Search results

• 2024

  Single-cell analysis of psoriasis resolution demonstrates an inflammatory fibroblast state targeted by IL-23 blockade

  Francis, L., McCluskey, D., Ganier, C., Jiang, T., Du-Harpur, X., Gabriel, J., Dhami, P., Kamra, Y., Visvanathan, S., Barker, J., Smith, C. H., Capon, F. & Mahil, S., 30 Jan 2024, In: Nature Communications. 15, 1, 913.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Analysis 100%
  • Psoriasis 100%
  • Cells 100%
  • Single-Cell Analysis 100%
  • Single Cell Analysis 100%
  9 Citations (Scopus)
• 2023

  A concept for integrated care pathways for atopic dermatitis—A GA²LEN ADCARE initiative

  Zuberbier, T., Abdul Latiff, A., Aggelidis, X., Augustin, M., Balan, R. G., Bangert, C., Beck, L., Bieber, T., Bernstein, J. A., Bertolin Colilla, M., Berardi, A., Bedbrook, A., Bindslev-Jensen, C., Bousquet, J., de Bruin-Weller, M., Bruscky, D., Buyuktiryaki, B., Canonica, G. W., Castro, C., Chanturidze, N., & 30 othersChong-Neto, H. J., Chu, C. Y., Chularojanamontri, L., Cork, M., Criado, R. F. J., Barredo, L. C., Custovic, A., Darsow, U., Emurlai, A., de Pablo, A., Del Giacco, S., Girolomoni, G., Deleva Jovanova, T., Deleuran, M., Douladiris, N., Duarte, B., Dubakiene, R., Eller, E., Engel-Yeger, B., Ensina, L. F., Filho, N. R., Flohr, C., Fomina, D., Francuzik, W., Galimberti, M. L., Giménez-Arnau, A. M., Godse, K., Mortz, C. G., Siemens, K. & Smith, C., Sept 2023, In: Clinical and translational allergy. 13, 9, e12299.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Quality 100%
  • Bright Futures 100%
  • Comorbidity 100%
  • Ordination 100%
  • Evidence-Based Treatment 100%
  2 Citations (Scopus)

• Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic

  Gleeson, D., Barker, J. N. W. N., Capon, F., Pink, A. E., Woolf, R. T., Smith, C. H. & Mahil, S. K., Apr 2023, In: The British journal of dermatology. 188, 4, p. 471-473 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  4 Citations (Scopus)

• Characteristics of "Super-Responders" and "Super-Non-Responders" to First Biologic Monotherapy for Psoriasis: A Nested Case-control Study

  BADBIR Study Group, 11 Nov 2023, (E-pub ahead of print) In: The British journal of dermatology.

  Research output: Contribution to journal › Article › peer-review

• Clinical and epidemiological features of psoriasis exacerbations in children with SARS-CoV-2 infection

  Skrek, S., Di Lernia, V., Beauchet, A., Bursztejn, A. C., Belloni Fortina, A., Lesiak, A., Thomas, J., Brzezinski, P., Topkarci, Z., Murashkin, N., Torres, T., Epishev, R., Chiriac, A., McPherson, T., Akinde, M., Maruani, A., Luna, P. C., Vidaurri de la Cruz, H., Mallet, S., Leducq, S., & 7 othersSergeant, M., Zitouni, J., Mahil, S. K., Smith, C. H., Flohr, C., Bachelez, H. & Mahé, E., Oct 2023, In: Journal of the European Academy of Dermatology and Venereology. 37, 10, p. e1192-e1195

  Research output: Contribution to journal › Letter › peer-review
  1 Citation (Scopus)

• Development of antidrug antibodies against adalimumab maps to variation within the HLA-DR peptide-binding groove

  Biomarkers of Systemic Treatment Outcomes in Psoriasis (BSTOP) Study Group, Tsakok, T., Saklatvala, J., Rispens, T., Loeff, F. C., de Vries, A., Allen, M. H., Barbosa, I. A., Baudry, D., Dasandi, T., Duckworth, M., Meynell, F., Russell, A., Chapman, A., McBride, S., McKenna, K., Perera, G., Ramsay, H., Ramesh, R., Sands, K., & 10 othersShipman, A., Burden, A. D., Griffiths, C. E., Reynolds, N. J., Warren, R. B., Mahil, S., Barker, J., Dand, N., Smith, C. & Simpson, M. A., 22 Feb 2023, In: JCI Insight. 8, 4, e156643.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Host Immune Response 100%
  2 Citations (Scopus)

• Electronic screening for mental illness in patients with psoriasis

  Bechman, K., Hayes, J. F., Mathewman, J., Henderson, A. D., Adesanya, E. I., Mansfield, K. E., Smith, C. H., Galloway, J. & Langan, S. M., Aug 2023, In: British Journal of Dermatology. 189, 2, p. 246-248 3 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access
  3 Citations (Scopus)

• Genetic validation of psoriasis phenotyping in UK Biobank supports the utility of self-reported data and composite definitions for large genetic and epidemiological studies

  Saklatvala, J. R., Hanscombe, K. B., Mahil, S. K., Tsoi, L. C., Elder, J. T., Barker, J. N., Simpson, M. A., Smith, C. H. & Dand, N., Aug 2023, In: Journal of Investigative Dermatology. 143, 8, p. 1598-1601.e10

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  File
  2 Citations (Scopus)

  68 Downloads (Pure)

• Nonadherence to systemic immune-modifying therapy in people with psoriasis during the COVID-19 pandemic: findings from a global cross-sectional survey

  PsoProtect study group, 20 Apr 2023, In: The British journal of dermatology. 188, 5, p. 610-617 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Anxiety 100%
  • Psoriasis 100%
  • Odds Ratio 100%
  • Cross Sectional Study 100%
  • Mental Health 80%
  4 Citations (Scopus)
• 2022

  Biomarkers of disease progression in people with psoriasis: a scoping review

  Ramessur, R., Corbett, M., Marshall, D., Acencio, M., Biscaia De Andrade Barbosa, I., Dand, N., Di Meglio, P., Haddad, S., Jensen, A., Koopmann, W., Mahil, S., Ostaszewski, M., Rahmatulla, S., Rastrick, J., Saklatvala, J., Weidinger, S., Wright, K., Eyerich, K., Ndlovu, M., Barker, J., & 3 othersSkov, L., Conrad, C. & Smith, C., Oct 2022, In: British Journal of Dermatology. 187, 4, p. 481-493 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Psoriasis 100%
  • Biological Marker 100%
  • Disease Exacerbation 100%
  • Prognostic Biomarker 100%
  • Genomics 100%
  34 Citations (Scopus)

  466 Downloads (Pure)

• Biomarkers of systemic treatment response in people with psoriasis: a scoping review

  Corbett, M., Ramessur, R., Marshall, D., Acencio, M., Ostaszewski, M., Biscaia De Andrade Barbosa, I., Dand, N., Di Meglio, P., Haddad, S., Jensen, A., Koopmann, W., Mahil, S., Rahmatulla, S., Rastrick, J., Saklatvala, J., Weidinger, S., Wright, K., Eyerich, K., Barker, J., Ndlovu, M., & 3 othersConrad, C., Skov, L. & Smith, C., Oct 2022, In: British Journal of Dermatology. 187, 4, p. 494-506 13 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Psoriasis 100%
  • Biological Marker 100%
  • Treatment Response 100%
  • Systemic Therapy 100%
  • Systemic Treatment 100%
  22 Citations (Scopus)

  109 Downloads (Pure)

• Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry)

  the Groupe de Recherche sur le Psoriasis (GrPso) of the Société Française de Dermatologie, the Groupe de recherche de la Société Française de Dermatologie Pédiatrique (GR SFDP), the PsoProtect study group, the British Society of Paediatric Dermatology (BPSD), and the Società Italiana di Dermatologia Pediatrica (S.I.Der.P.), Nov 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 11, p. 2076-2086 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Psoriasis 100%
  • Infection 100%
  • COVID-19 100%
  • Disease Exacerbation 100%
  • Child 100%
  10 Citations (Scopus)

• Comparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling

  the BADBIR Study Group & the BSTOP study group, Sept 2022, In: Arthritis and Rheumatology. 74, 9, p. 1535-1543 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Heritability 100%
  • Comparative Genomics 100%
  • Genetics 25%
  • Wnt Signaling Pathway 25%
  • Single-Nucleotide Polymorphism 25%
  19 Citations (Scopus)

  109 Downloads (Pure)

• Damaging alleles affecting multiple CARD14 domains are associated with palmoplantar pustulosis

  Niaouris, T., Hernandez Cordero, A., Haddad, S., Hassi, K., Benzian Olsson, N., Bugarin Diz, C., Burden, A. D., Cooper, H., Griffiths, C. E., Parslew, R., Pink, A. E., Reynolds, N. J., Wahie, S., Warren, R. B., Wright, A., Simpson, M., Baum, P., Visvanathan, S., Barker, J. N., Smith, C. H., & 1 othersCapon, F., 26 Sept 2022, (Accepted/In press) In: Journal of Investigative Dermatology.

  Research output: Contribution to journal › Letter › peer-review

• Differences in Clinical Features and Comorbid Burden between HLA-C∗06:02 Carrier Groups in >9,000 People with Psoriasis

  BADBIR & BSTOP Study Groups, Jun 2022, In: Journal of Investigative Dermatology. 142, 6, p. 1617-1628.e10

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Psoriasis 100%
  • Clinical Feature 100%
  • Waist Circumference 100%
  • Genetics 50%
  • Biomarker Study 50%
  13 Citations (Scopus)

• Drug Survival Associated with Effectiveness and Safety of Treatment with Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients with Psoriasis

  Yiu, Z. Z. N., Becher, G., Kirby, B., Laws, P., Reynolds, N. J., Smith, C. H., Warren, R. B. & Griffiths, C. E. M., Oct 2022, In: JAMA dermatology. 158, 10, p. 1131-1141 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Ixekizumab 100%
  • Tolerability 5%
  • Prospective Cohort Study 5%
  • Cohort Study 5%
  78 Citations (Scopus)

• Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs

  Tucker, L., Allen, A., Chandler, D., Ciurtin, C., Dick, A., Foulkes, A., Gullick, N., Helliwell, P., Jadon, D., Jones, G., Kyle, S., Madhok, V., McHugh, N., Parkinson, A., Raine, T., Siebert, S., Smith, C., Tillett, W. & Coates, L. C., 30 Aug 2022, In: Rheumatology (Oxford, England). 61, 9, p. 3514-3520 7 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Genome-wide association meta-analysis identifies 29 new acne susceptibility loci

  Mitchell, B. L., Saklatvala, J. R., Dand, N., Hagenbeek, F. A., Li, X., Min, J. L., Thomas, L., Bartels, M., Jan Hottenga, J., Lupton, M. K., Boomsma, D. I., Dong, X., Hveem, K., Løset, M., Martin, N. G., Barker, J. N., Han, J., Smith, C. H., Rentería, M. E. & Simpson, M. A., Dec 2022, In: Nature Communications. 13, 1, 702.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Association 100%
  • Meta-Analysis 100%
  • Acneiform Eruption 100%
  • Dermatosis 33%
  • Malignant Neoplasm 16%
  22 Citations (Scopus)

• Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study

  Mahil, S. K., Bechman, K., Raharja, A., Domingo-Vila, C., Baudry, D., Brown, M. A., Cope, A. P., Dasandi, T., Graham, C., Khan, H., Lechmere, T., Malim, M. H., Meynell, F., Pollock, E., Sychowska, K., Barker, J. N., Norton, S., Galloway, J. B., Doores, K. J., Tree, T., & 1 othersSmith, C. H., Jan 2022, In: The Lancet Rheumatology. 4, 1, p. e42-e52

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Immunosuppressive Treatment 100%
  • Cohort Analysis 100%
  • COVID-19 Vaccine 100%
  • Immunosuppression 100%
  • Immunogenicity 100%
  67 Citations (Scopus)

  101 Downloads (Pure)

• Infection profile of immune-modulatory drugs used in autoimmune diseases: Analysis of summary of product characteristic data

  Dey, M., Bechman, K., Zhao, S., Fragoulis, G. E., Smith, C., Cope, A., Nikiphorou, E., Hyrich, K. L. & Galloway, J., 23 Nov 2022, In: RMD Open. 8, 2, 002621.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pharmacovigilance 100%
  • Clinical Trial 50%
  • Organisms 50%
  • Respiratory Tract 50%
  • Infectious Agent 50%
  3 Citations (Scopus)

• Infection profile of immune-modulatory drugs used in autoimmune diseases: analysis of summary of product characteristic data

  Dey, M., Bechman, K., Zhao, S., Fragoulis, G. E., Smith, C., Cope, A., Nikiphorou, E., Hyrich, K. L. & Galloway, J., Nov 2022, In: RMD Open. 8, 2

  Research output: Contribution to journal › Review article › peer-review

  • Pharmacovigilance 100%
  • Clinical Trial 50%
  • Organisms 50%
  • Respiratory Tract 50%
  • Infectious Agent 50%

• Infection profile of immune-modulatory drugs used in autoimmune diseases: Analysis of summary of product characteristic data

  Dey, M., Bechman, K., Zhao, S. S., Fragoulis, G. E., Smith, C. H., Cope, A., Nikiphorou, E., Hyrich, K. L. & Galloway, J., 10 Oct 2022, (Accepted/In press) In: RMD Open.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Pharmacovigilance 100%
  • Clinical Trial 50%
  • Organisms 50%
  • Respiratory Tract 50%
  • Infectious Agent 50%
  34 Downloads (Pure)

• Requirements and expectations of high-quality biomarkers for atopic dermatitis and psoriasis in 2021—a two-round Delphi survey among international experts

  Ziehfreund, S., Tizek, L., Hangel, N., Fritzsche, M. C., Weidinger, S., Smith, C., Bryce, P. J., Greco, D., van den Bogaard, E. H., Flohr, C., Rastrick, J., Eyerich, S., Buyx, A., Conrad, C., Eyerich, K. & Zink, A., Sept 2022, In: Journal of the European Academy of Dermatology and Venereology. 36, 9, p. 1467-1476 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Biomarker Research 100%
  21 Citations (Scopus)

• Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform

  MacKenna, B., Kennedy, N. A., Mehrkar, A., Rowan, A., Galloway, J., Matthewman, J., Mansfield, K. E., Bechman, K., Yates, M., Brown, J., Schultze, A., Norton, S., Walker, A. J., Morton, C. E., Harrison, D., Bhaskaran, K., Rentsch, C. T., Williamson, E., Croker, R., Bacon, S., & 28 othersHickman, G., Ward, T., Davy, S., Green, A., Fisher, L., Hulme, W., Bates, C., Curtis, H. J., Tazare, J., Eggo, R. M., Evans, D., Inglesby, P., Cockburn, J., McDonald, H. I., Tomlinson, L. A., Mathur, R., Wong, A. Y. S., Forbes, H., Parry, J., Hester, F., Harper, S., Douglas, I. J., Smeeth, L., Lees, C. W., Evans, S. J. W., Goldacre, B., Smith, C. H. & Langan, S. M., Jul 2022, In: The Lancet Rheumatology. 4, 7, p. e490-e506

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Therapeutic Procedure 100%
  • Immunity 100%
  • COVID-19 100%
  • Inflammatory Disorder 100%
  • Cohort Analysis 100%
  67 Citations (Scopus)

• Single-cell analysis implicates Th17 to Th2 cell plasticity in the pathogenesis of palmoplantar pustulosis

  APRICOT and PLUM study team, Oct 2022, In: Journal of Allergy and Clinical Immunology. 150, 4, p. 882-893 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Single Cell Analysis 100%
  • T-Helper Cell 33%
  • T Cell Activation 33%
  • Atopic Dermatitis 16%
  • Plasticity 16%
  31 Citations (Scopus)

  82 Downloads (Pure)

• The Impact of Immune-Modifying Treatments for Skin Diseases on the Immune Response to COVID-19 Vaccines: a Narrative Review

  Liew, S. Y., Tree, T., Smith, C. H. & Mahil, S. K., Dec 2022, In: Current Dermatology Reports. 11, 4, p. 263-288 26 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Therapeutic Procedure 100%
  • Immunity 100%
  • Immune Response 100%
  • Dermatosis 100%
  • COVID-19 Vaccine 100%
  3 Citations (Scopus)

• The importance of illness severity and multimorbidity in the association between mental health and body weight in psoriasis: Cross-sectional and longitudinal analysis

  Pavlova, N. T., Moss-Morris, R., Smith, C., Carr, E., Rayner, L. & Picariello, F., 19 Apr 2022, In: Skin Health and Disease. 2, 4, 12 p., e117.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Mental Health 100%
  • Psoriasis 100%
  • Longitudinal Analysis 100%
  • Demographics 44%
  • Anxiety 44%
  3 Citations (Scopus)

  94 Downloads (Pure)

• Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey

  PsoProtect study group, Bechman, K., Cook, E. S., Dand, N., Yiu, Z. Z. N., Tsakok, T., Meynell, F., Coker, B., Vincent, A., Bachelez, H., Barbosa, I., Brown, M. A., Capon, F., Contreras, C. R., De La Cruz, C., Di Meglio, P., Gisondi, P., Jullien, D., Kelly, J., Lambert, J., & 20 othersLancelot, C., Langan, S. M., Mason, K. J., McAteer, H., Moorhead, L., Naldi, L., Norton, S., Puig, L., Spuls, P. I., Torres, T., Urmston, D., Vesty, A., Warren, R. B., Waweru, H., Weinman, J., Griffiths, C. M., Barker, J. N., Smith, C. H., Galloway, J. B. & Mahil, S. K., Aug 2022, In: The British journal of dermatology. 187, 2, p. 254-256 3 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  9 Citations (Scopus)
• 2021

  Anakinra for palmoplantar pustulosis: results from a randomized, double-blind, multicentre, two-staged, adaptive placebo-controlled trial (APRICOT)

  the APRICOT Study Group, 12 Oct 2021, (E-pub ahead of print) In: British Journal of Dermatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pustulosis Palmaris Et Plantaris 100%
  • Anakinra 100%
  • Therapeutic Procedure 30%
  • Arm 20%
  • Pustule 20%
  18 Citations (Scopus)

• Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models

  BADBIR Study Group & BSTOP study group, Dec 2021, In: Scientific Reports. 11, 1, 23335.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Feature Selection 100%
  • Prediction Model 100%
  • Genetics 50%
  • Training 37%
  • Algorithms 25%
  17 Citations (Scopus)

• Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19

  Izadi, Z., Brenner, E. J., Mahil, S. K., Dand, N., Yiu, Z. Z. N., Yates, M., Ungaro, R. C., Zhang, X., Agrawal, M., Colombel, J. F., Gianfrancesco, M. A., Hyrich, K. L., Strangfeld, A., Carmona, L., Mateus, E. F., Lawson-Tovey, S., Klingberg, E., Cuomo, G., Caprioli, M., Cruz-Machado, A. R., & 45 othersMazeda Pereira, A. C., Hasseli, R., Pfeil, A., Lorenz, H. M., Hoyer, B. F., Trupin, L., Rush, S., Katz, P., Schmajuk, G., Jacobsohn, L., Seet, A. M., Al Emadi, S., Wise, L., Gilbert, E. L., Duarte-García, A., Valenzuela-Almada, M. O., Isnardi, C. A., Quintana, R., Soriano, E. R., Hsu, T. Y. T., D'Silva, K. M., Sparks, J. A., Patel, N. J., Xavier, R. M., Marques, C. D. L., Kakehasi, A. M., Flipo, R. M., Claudepierre, P., Cantagrel, A., Goupille, P., Wallace, Z. S., Bhana, S., Costello, W., Grainger, R., Hausmann, J. S., Liew, J. W., Sirotich, E., Sufka, P., Robinson, P. C., Machado, P. M., Griffiths, C. E. M., Barker, J. N., Smith, C. H., Yazdany, J. & Kappelman, M. D., 1 Oct 2021, In: JAMA Network open. 4, 10, p. e2129639

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Patient 100%
  • Immunity 100%
  • COVID-19 100%
  • Association 100%
  • Inflammatory Disorder 100%
  91 Citations (Scopus)

• Characteristics and skin cancer risk of psoriasis patients with a history of skin cancer in BADBIR

  the BADBIR Study Group, Aug 2021, In: Journal of the European Academy of Dermatology and Venereology. 35, 8, p. e498-e501

  Research output: Contribution to journal › Letter › peer-review
  2 Citations (Scopus)

• Defining trajectories of response in patients with psoriasis treated with biologic therapies

  the BADBIR Study Group & the PSORT Consortium, Oct 2021, In: British Journal of Dermatology. 185, 4, p. 825-835 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Patient 100%
  • Psoriasis 100%
  • Biological Therapy 100%
  • Clinical Trial 100%
  • Disease 16%
  5 Citations (Scopus)

• Dermatology COVID-19 Registries: Updates and Future Directions

  Freeman, E. E., Chamberlin, G. C., McMahon, D. E., Hruza, G. J., Wall, D., Meah, N., Sinclair, R., Balogh, E. A., Feldman, S. R., Lowes, M. A., Marzano, A. V., Naik, H. B., Castelo-Soccio, L., Lara-Corrales, I., Cordoro, K. M., Mahil, S. K., Griffiths, C. E. M., Smith, C. H., Irvine, A. D., Spuls, P. I., & 2 othersFlohr, C. & French, L. E., 1 Oct 2021, In: Dermatologic clinics. 39, 4, p. 575-585 11 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • COVID-19 100%
  • Dermatology 100%
  • Patient 66%
  • Public Health 33%
  • Physician 33%
  12 Citations (Scopus)

• Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study

  PsoProtect study group, Oct 2021, In: Journal of the European Academy of Dermatology and Venereology : JEADV. 35, 10, p. e636-e640

  Research output: Contribution to journal › Article › peer-review

  • Psoriasis 100%
  • COVID-19 100%
  • Cross Sectional Study 100%
  • Cross-Sectional Study 100%
  • Nutrition Policy 100%
  14 Citations (Scopus)

• DIFFERENCES IN CLINICAL FEATURES AND COMORBID BURDEN BETWEEN HLA-C*06:02 CARRIER GROUPS IN MORE THAN 9,000 PEOPLE WITH PSORIASIS

  Douroudis, K., Ramessur, R., Biscaia De Andrade Barbosa, I., Baudry, D., Duckworth, M., Angit, C., Capon, F., Chung, R., Curtis, C., DiMeglio, P., Goudling, J., Griffiths, C., Lee, S., Mahil, S., Parslew, R., Reynolds, N., Shipman, A., warren, R., Yiu, Z., Simpson, M., & 3 othersBarker, J., Dand, N. & Smith, C., 21 Nov 2021, In: Journal of Investigative Dermatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Psoriasis 100%
  • Clinical Feature 100%
  • Disease 42%
  • UK Biobank 42%
  • Medicine 28%
  165 Downloads (Pure)

• Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis

  Andres Ejarque, R., Ale, H. B. A., Grys, K., Tosi, I., Solanky, S., Ainali, C., Catak, Z., Sreeneebus, H., Saklatvala, J., Dand, N., de Rinaldis, E., Chapman, A., Nestle, F., Barnes, M. R., Richard, W., Reynolds, N. J., Griffiths, C., Barker, J., Smith, C., Di Meglio, P., & 1 othersCOnsortium, PSORT., 6 Aug 2021, In: Nature Communications. 12, 1, p. 4741 1 p., 4741.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Phosphorylation 100%
  • Tumor Necrosis Factor 100%
  • CD83 50%
  26 Citations (Scopus)

  106 Downloads (Pure)

• Learning from disease registries during a pandemic: Moving toward an international federation of patient registries

  Wall, D., Alhusayen, R., Arents, B., Apfelbacher, C., Balogh, E. A., Bokhari, L., Bloem, M., Bosma, A. L., Burton, T., Castelo-Soccio, L., Fagan, N., Feldman, S. R., Fletcher, G., Flohr, C., Freeman, E., French, L. E., Griffiths, C. E. M., Hruza, G. J., Ingram, J. R., Kappelman, M. D., & 14 othersLara-Corrales, I., Lim, H. W., Meah, N., McMahon, D. E., Mahil, S. K., McNicoll, I., Musters, A., Naik, H. B., Sinclair, R., Smith, C. H., Spuls, P., Tobin, D. J., York, K. & Irvine, A. D., 1 May 2021, In: Clinics in Dermatology. 39, 3, p. 467-478 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Disease 100%
  • Patient Registry 100%
  • Dermatology 57%
  • Patient 14%
  • COVID-19 14%
  9 Citations (Scopus)

• Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy Showcase

  PSORT consortium, Aug 2021, In: Journal of Investigative Dermatology. 141, 8, p. 1872-1878 7 p.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

  • Therapeutic Procedure 100%
  • Psoriasis 100%
  • Medicine 37%
  • Patient 12%
  • Medical Research 12%
  3 Citations (Scopus)

• Patient preferences for stratified medicine in psoriasis: a discrete choice experiment

  the PSORT Consortium, Nov 2021, In: British Journal of Dermatology. 185, 5, p. 978-987 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Psoriasis 100%
  • Patient Preference 100%
  • Medicine 100%
  • Biological Product 50%
  • Calculator 50%
  6 Citations (Scopus)

• Psychosocial aspects of obesity in adults with psoriasis: A systematic review

  Pavlova, N. T., Kioskli, K., Smith, C., Picariello, F., Rayner, L. & Moss-Morris, R., Jun 2021, In: Skin Health and Disease. 1, 2, e33.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Adult 100%
  • Systematic Review 100%
  • Patient Social Context 100%
  • Psoriasis 100%
  • Quality 60%
  10 Citations (Scopus)

• Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis–Correction

  Smith, C. H., Mahil, S. K., Yiu, Z. Z. N., Bale, T., Burden, A. D., Coates, L. C., McGuire, A., Murphy, R., Owen, C. M., Parslew, R., Uthman, O. A., Woolf, R. T., Manounah, L., Ezejimofor, M. C., Exton, L. S. & Mohd Mustapa, M. F., Jan 2021, In: Journal of Investigative Dermatology. 141, 1, p. 177-181 5 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)

• Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis: a single-centre, prospective 1-year observational cohort study of the first 100 patients treated

  Sears, A. V., Woolf, R. T., Gribaleva, E., Abdelrahman, W., Robbie, S., Menon, B., Kirkham, B., Smith, C. H. & Pink, A. E., Apr 2021, In: British Journal of Dermatology. 184, 4, p. 755-757 3 p.

  Research output: Contribution to journal › Letter › peer-review
  38 Citations (Scopus)

• Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs non-biologic systemic therapies

  the BADBIR Study Group, Aug 2021, In: Journal of the European Academy of Dermatology and Venereology. 35, 8, p. e496-e498

  Research output: Contribution to journal › Letter › peer-review
  2 Citations (Scopus)

• The BIOMarkers in Atopic Dermatitis and Psoriasis (BIOMAP) glossary: developing a lingua franca to facilitate data harmonization and cross-cohort analyses

  the BIOMAP consortium, Broderick, C., Christian, N., Apfelbacher, C., Bosma, A. L., Dand, N., Ghosh, S., Hangel, N., Hübenthal, M., Middelkamp-Hup, M. A., Min, J. L., Musters, A. H., Paternoster, L., Rodríguez, E., Satagopam, V., Scordis, P., Spuls, P. I., Szymczak, S., Weidinger, S., Smith, C. H., & 1 othersFlohr, C., Nov 2021, In: British Journal of Dermatology. 185, 5, p. 1066-1069 4 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

  File
  12 Citations (Scopus)

  51 Downloads (Pure)

• The power and potential of BIOMAP to elucidate host-microbiome interplay in skin inflammatory diseases

  Alenius, H., Sinkko, H., Moitinho-Silva, L., Rodriguez, E., Broderick, C., Alexander, H., Reiger, M., Hjelmsø, M. H., Fyhrquist, N., Olah, P., Bryce, P., Smith, C., Koning, F., Eyerich, K., Greco, D., van den Bogaard, E. H., Neumann, A. U., Traidl-Hoffmann, C., Homey, B., Flohr, C., & 3 othersBønnelykke, K., Stokholm, J. & Weidinger, S., Oct 2021, In: Experimental Dermatology. 30, 10, p. 1517-1531 15 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Atopic Dermatitis 100%
  • Solution and Solubility 50%
  • Microorganism 50%
  • Gut Microbiome 16%
  7 Citations (Scopus)
• 2020

  A randomised placebo controlled trial of anakinra for treating pustular psoriasis: Statistical analysis plan for stage two of the APRICOT trial

  Cro, S., Patel, P., Barker, J., Burden, D. A., Griffiths, C. E. M., Lachmann, H. J., Reynolds, N. J., Warren, R. B., Capon, F., Smith, C. & Cornelius, V., 10 Feb 2020, In: Trials. 21, 1, 158.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Statistical Analysis 100%
  • Pustular Psoriasis 100%
  • Anakinra 100%
  • Analysis 75%
  • Therapeutic Procedure 50%
  6 Citations (Scopus)

• Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis: Findings from the APRICOT, PLUM and ERASPEN consortia

  ERASPEN consortium and the APRICOT and PLUM study team, Nov 2020, In: JAMA dermatology. 156, 11, p. 1216-1222 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Pustulosis Palmaris Et Plantaris 100%
  • Europeans 100%
  • Men 66%
  • Women 66%
  • Patient 54%
  19 Citations (Scopus)

• Clinical Impact of Antibodies against Ustekinumab in Psoriasis: An Observational, Cross-Sectional, Multicenter Study

  BADBIR, BSTOP Study Groups & PSORT consortium, Nov 2020, In: Journal of Investigative Dermatology. 140, 11, p. 2129-2137 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Enzyme-Linked Immunosorbent Assay 100%
  • Radioimmunoassay 75%
  7 Citations (Scopus)

• CYP1A1 enzymatic activity influences skin inflammation via regulation of the AHR pathway

  Kyoreva, M., Li, Y., Hoosenally, M., Hardman-Smart, J., Morrison, K., Tosi, I., Tolaini, M., Barinaga, G., Stockinger, B., Mrowietz, U., Nestle, F., Smith, C., Barker, J. & Di Meglio, P., 29 Dec 2020, (E-pub ahead of print) In: Journal of Investigative Dermatology.

  Research output: Contribution to journal › Article › peer-review

  Open Access
  41 Citations (Scopus)

  30 Downloads (Pure)